chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The administered vaccine expired July 15 2023, upon calling the manufacturer the representative stated that according to the stability data they have for MMR II with the above expiration date, the dose is still stable and the patient doesn't need to repeat the dose.  Further, upon talking to the patient, she is not experiencing or has experienced any side effects as of now.
Within 20 minutes, the pt experienced a headache, chest pain, diaphoresis, bradycardia.
Urticaria to neck at 11:00, approx 2.5 hrs after immunization. No airway involvement. Took Zyrtec 10mg.
Broken out in a very itchy rash, similar to poison ivy reactions, started as a small patch of small reds bumps, spread from injection site to other shoulder and down the back some. It's been two days so far.
Vaccine expired on 26Feb2023, moved to refrigerator on 14Mar2023 and administered on 15Mar2023; No adverse event; She had expired vaccine that was administered on March 15,2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (She had expired vaccine that was administered on March 15,2023), PRODUCT STORAGE ERROR (Vaccine expired on 26Feb2023, moved to refrigerator on 14Mar2023 and administered on 15Mar2023) and NO ADVERSE EVENT (No adverse event) in a 21-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 060B22A) for COVID-19 prophylaxis.     It was unknown if the patient had tested positive or diagnosed with COVID-19 previously.     On 15-Mar-2023, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 15-Mar-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (She had expired vaccine that was administered on March 15,2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 26Feb2023, moved to refrigerator on 14Mar2023 and administered on 15Mar2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (She had expired vaccine that was administered on March 15,2023), PRODUCT STORAGE ERROR (Vaccine expired on 26Feb2023, moved to refrigerator on 14Mar2023 and administered on 15Mar2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (She had expired vaccine that was administered on March 15,2023) and PRODUCT STORAGE ERROR (Vaccine expired on 26Feb2023, moved to refrigerator on 14Mar2023 and administered on 15Mar2023).    No concomitant medication details were reported.  Vial size was reported as 10 dose vials. The vial was initially stored in the refrigerator on 14-MAR-2023. The vial did not undergo any temperature excursions.  It was reported that expired Moderna COVID-19 monovalent vaccine was administered on 15-MAR-2023. HCP wanted to know if the vaccine administered on 15-MAR-2023 would be considered valid for the patient.  No treatment medication details were reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-716065 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-716065:Master Case
This spontaneous report as received from a physician refers to four unspecified patients. On unknown dates the patients were vaccinated with ZOSTAVAX (lot # reported as K000455, Exp date: 30-OCT-2014), 0.65 ml, subcutaneous. The physician reported 4 out of 10 patients were vaccinated with same lot of ZOSTAVAX and developed severe reactions. Multiple injection site reactions which included: angry red swelling at the injection site which cascaded down the arm to the elbow. Redness and swelling circumference around the injected arm. Blisters at the site, which physician confirms was not shingles. Physician stated the last 4 weeks was the most adverse effects she had seen with the ZOSTAVAX vaccine. Physician stated she had seen this change since the last batch label change from 3 piece label to one label. The physician stated one of her patients, who had the reaction to ZOSTAVAX, was scheduled to come into the office today. The outcome of the events was unknown. ZOSTAVAX Lot Check Request K000455 Exp 30-OCT-2014. This is one of several reports from the same source. Additional information has been requested.
Within weeks of vaccine administration patient had fevers, lethargy, diarrhea and body aches. This continued since the initial vaccination every 2-4 weeks in a previously healthy male. Patient never had acute illness this frequently in life. Treatments included antiviral medications, herbal immune support, NSAIDS, dietary changes, vitamins, antibiotics and IV therapies.
Head ache and temperature of at least 101.8*.  extreme relactation, meditation, deep breathing and soft music.
Patient is COVID positive after exposure via contact with family member who was also positive (vaccination status unknown) She was treated with Regeneron and has had no supplemental oxygen requirement during her hospitalization
I developed Covid -19 (positive PCR) on 02Jan2021 after respecting quarantine, mask wearing, and was not onsite at work; I developed Covid -19 (positive PCR) on 02Jan2021 after respecting quarantine, mask wearing, and was not onsite at work; This is a spontaneous report from a contactable  pharmacist. A 25-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) lot number: EK5130, via an unspecified route of administration at left arm from 23Dec2020 16:30 to 23Dec2020 16:30 at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient developed Covid-19 (positive polymerase chain reaction (PRC)) on 02Jan2021, after respecting quarantine, mask wearing, and was not onsite at work. The patient did not received treatment for the adverse events. The outcome of the events was recovering.; Sender's Comments: A causal association between reported event and suspect BNT162B2 cannot be excluded.
Fever; Headache; Chills; Fatigue; Swollen lymph nodes in rightunderarm; This is a spontaneous report from a non-contactable other healthcare professional (the patient). A 32-year-old, non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route on right arm on 21Mar2021 at 18:15 (at the age of 32-year-old) as single dose for COVID-19 immunisation. The medical history of the patient was not reported. Concomitant medication included unspecified birth control. The patient had no known allergies. The patient did not receive any other vaccination within 4 weeks prior to the COVID vaccine. The patient had tested positive prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 22Mar2021, the patient experienced fever, headache, chills, fatigue and swollen lymph nodes in right underarm. The patient did not receive any treatment for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The outcome for the events of fever, headache, chills, fatigue and swollen lymph nodes in right underarm was recovering at the time of this report   Information about lot number cannot be obtained. No further information is expected.
Diffuse papular rash beginning on abdomen, then over the next 24 hours spreading to groin, back, proximal extremities, posterior head, and face.  No fevers.  Irritability and decreased appetite.
Pt recvd vax MAY or JUN2 & w/in 6 hrs following vax pt devel fever of 100.8 & chills, aches, & fatigue; pt recovered in approx 2 days;
Patient has known lymphoma but was on break from chemotherapy. No known lung disease. She developed a very large left pleural effusion and became markedly hypoxia need chest tube drainage. Multiple fluid cultures were negative for infection and fluid sent twice for cytology and flow cytometry were negative for tumor cells. She was too  ?sick? for thoracoscopy. Over the next  7 days the symptoms resolved and the effusion has not returned which speaks against this being from the lymphoma. She had symptoms the night of the vaccine but did not become critically ill for about 36 hours as the effusion was developing. Her oncologist and I both believe this was related to the vaccine and will not give the second dose.
Edema / swelling  from chest down to feet.   1st day after vaccine I noticed some swelling in my feet,  2nd day after vaccine I had 2+ edema in my legs & feet, 3rd day after vaccine I had 3+ pitting edema in my feet and swelling from my chest/abd down to my feet.  I initially did not contribute this to the Covid vaccine but thought I was having complications from my surgery.  However, I had not had any adverse reactions from my surgery and I had been going to follow up visits weekly with the surgeon.  I went to the ER  on 1/24/21 because I had gained 13 lbs. in fluid over a 3 day period and thought it could be a DVT or CHF.
lips and face swelled; lips and face swelled; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (lips and face swelled) and SWELLING FACE (lips and face swelled) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032LZ0A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced LIP SWELLING (lips and face swelled) and SWELLING FACE (lips and face swelled). At the time of the report, LIP SWELLING (lips and face swelled) and SWELLING FACE (lips and face swelled) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant product use was not provided by the reporter.   Treatment medication included 2 doses of diphenhydramine (Benadryl) within a 24-hour period.     Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: form was attached and it contains NNI
Pt received 4 yo vaccines on Tues 9-23-15. Pt ran low grade temp that p.m. No other issues. Friday when aunt picked him up at pre-K pt had 2 blisters on (L) lower leg. School nurse unsure what the cause. Pt grandparent applied Band-Aid over the blisters that popped Fri PM. Small rash, irritation type, around 2 almost healed blisters on (L) lower leg in shape of Band-Aid. No s/s of infection. Aunt whom has custody states he is fine just don't know what the blisters were from and making sore not from vacc. Nurse adv aunt as lets take to PCP she declined.
5 hours status post vaccination, c/o facial itching.  Itching slowly started on neck, and arm.  Slight hives noted on R arm, back and near L chest area.  NO difficulty breathing, no noted stridor.
Pt vaccinated at 12:13 pm with COVID-19 Moderna, 1st dose. While waiting in her car at the observation station of the drive-thru site for 30 minutes due to hx of chest tighntess due to scents and chemicals, pt began to feel like her chest and hands were itching at 12:40 pm. Alert and talking, no distress noted.  Pt given benadryl 25 mg tab at 11:49 a pm. Pt remained on site another 30 minutes. No worsening of symptoms and reported improvement.  Pt was discharged to home via her own car with husband driving at 1:20 pm. Called the next day to check on pt. She took another benadryl that night. No further problems.
Nausea; exhausted, no energy; no energy; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), FATIGUE (exhausted, no energy) and ASTHENIA (no energy) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea), FATIGUE (exhausted, no energy) and ASTHENIA (no energy). At the time of the report, NAUSEA (Nausea), FATIGUE (exhausted, no energy) and ASTHENIA (no energy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant no treatment medication included.   This case was linked to US-MODERNATX, INC.-MOD-2021-089048, US-MODERNATX, INC.-MOD-2021-089362 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow up report received on 27-May-2021 contains No New Information.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-089048:patient 1 US-MODERNATX, INC.-MOD-2021-089362:patient 2
Pain and erythema at injection site (approx 3). No temp 98.2. UR cough. General malaise. Headache.
given a dose of Havrix/ deemed nonviable after a temperature excursion; This case was reported by a physician via call center representative and described the occurrence of incorrect storage of drug in a 39-year-old male patient who received HAV (Havrix) (batch number N39BM, expiry date 31st January 2022) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 9th June 2021, the patient received Havrix and Havrix Pre-Filled Syringe Device. On 9th June 2021, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional case details were reported as follows: The patient was given a dose of Havrix that was deemed nonviable after a temperature excursion, which led to incorrect storage of drug.  No symptoms reported. The reporter consented to follow up. This case was 2nd from 6 case reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021142812:Same reporter US-GLAXOSMITHKLINE-US2021142818:Same reporter US-GLAXOSMITHKLINE-US2021142817:Same reporter US-GLAXOSMITHKLINE-US2021142816:Same reporter US-GLAXOSMITHKLINE-US2021142815:Same reporter
Reported Feeling "hot and nauseous" immediately after shot. Complained of being dizzy. Reclined. BP was 90/60.  Vomited twice.  After 10 minutes felt better.  BP now 110/70.
Pt received 0.5 ml FLUZONE MD on  9/18/10 1pm. I received a call from patient's wife at 4:30 pm expressing that her husband did not feel well. She said he had a general feeling of sickness and also felt like vomiting. I told her to go to the nearest ER or to call 911.
TD placed 10/25/11 called 11/2/11 c/o arm swollen, blotchy & red, itching. Tx BENADRYL prn.
This literature report (initial receipt: 13-Nov-2012) concerns a 49-year-old male patient. The patient had a recent history of viral infection status post flu vaccination (manufacturer, brand name and batch number were not provided). On an unknown date (post viral infection) the patient presented with a 2-week history of bilateral lower extremity weakness and paresthesias starting at the level of the axilla. He was evaluated by Neurology and initially diagnosed with transverse myelitis. He underwent intravenous immunoglobulin and steroid treatment without improvement. The patient's physical examination revealed 3/5 proximal and 5/5 distal muscle strength in the lower extremities, deep tendon reflexes were 2/4 with no upper motor neuron signs visualized. He was medically stabilized and transferred to inpatient rehabilitation facility. Ten days post admission, the patient experienced acute motor loss (0/5) in bilateral lower extremities and worsening paresthesias, now involving bilateral upper extremities. At 10 days post admission, imaging revealed C7 to T2 diffuse cord expansion and an oval-shaped focus of intramedullary enhancement. Prior to the completion of his medical work-up, the patient passed away due to unclear causes. Death was most likely related to respiratory compromise. Post mortem autopsy results showed histopathological diagnosis of primary glioblastoma multiforme of the spinal cord. Reporter's comment: This is a rare documented case of primary spinal glioblastoma multiforme in an adult patient. Mean survival time after onset is between 6-16 months. The major cause of death is leptomeningeal spread and cerebral metastasis. Cervical glioblastoma multiforme may have an even poorer outcome because of early involvement of the phrenic nerve nucleus and vasomotor centers.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 18-Feb-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 18-Feb-2022; Patient administered 0.25 ml for dose 1.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 18-Feb-2022), UNDERDOSE (Patient administered 0.25 ml for dose 1.) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 18-Feb-2022) in a 25-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 066H21A) for COVID-19 vaccination.     It was unknown if patient had any acute illnesses at the time of vaccination and up to one month before. It was unknown if the patient had chronic or long-standing health conditions.     On 18-Feb-2022 at 6:22 PM, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) .25 milliliter. On 18-Feb-2022 at 6:22 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 18-Feb-2022) and UNDERDOSE (Patient administered 0.25 ml for dose 1.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 18-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 18-Feb-2022), UNDERDOSE (Patient administered 0.25 ml for dose 1.) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 18-Feb-2022) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   It was unknown if any prescriptions, over-the-counter-medications, dietary supplements, or herbal remedies were being taken by the patient at the time of vaccination and/or at the time of the adverse event. It was unknown if other vaccines were given on the same day or within one month prior to any dose of as Moderna COVID-19 Vaccine to the patient.  Patient received first dose. Patient ethnicity reported as multiethnic. The patient received Moderna vaccine past its 30 day of expiry date. Vaccine went into 2 to 8 degree Celsius thaw state on or about 24-Dec-2021. This vaccine was administered up until its manufacturing expiry date of 04-Apr-2022. We no longer possess this lot number.  No treatment information was provided
ONE HOUR AFTER H1N1 BODY TEMP DECREASED 96 DEGREES TO 98 DEGREES COMPLAINING COLD INSIDE AND LIPS TURNED PURPLE.  COMPLAINED THAT WHEN INHALING IT FELT LIKE ICE.  TWO DAYS LATER BODY TEMPERATURE 100 DEGREES BACK ACHES AND CONTINUED TO INHALE COLD/ICY AIR.
Product storage error; 606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Product storage error) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Product storage error). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Product storage error) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided by the reporter  It was mentioned that the vial was initially refrigerated on 26-Oct-2021, the vial did not undergo any temperature excursion and patient did not experienced any adverse events.  No treatment medication was provided by the reporter.
8 days after shot came down with the full blown measles, I had a high fever for 3 days could barely move or talk. My tonsils and all my lymph nodes swelled up! After the fever broke came down with a rash all over my body! It has been 3 months and my tonsils and lymph nodes are still swollen, also got painful tonsillitis and had to pay out of pocket for an ENT to see me! And once he found out I was vaccine injured he pushed it under the rug. And I have been having joint pain and tonsils still swollen! I don't have the money to actually see what's going on so who knows what this vaccine has really done to my health.
About 45 minutes after vaccine resident reported feeling light headed. Pulse was elevated at 120. Administered PRN Benadryl per protocol. Resident drank Gatorade and ate some food. Reported chest pain 15 minutes later. Administered PRN nitro which relieved his chest pain significantly.
On 4/19/22 at 9:02 AM, a flu vaccine was administered to the pt, despite the pt having received one in September 2021. Per staff report, the September dose in database was not observed due to the most recent administration being at the bottom of the record.  Pt was monitored for 15 minutes after receiving both the flu and Moderna vaccines. No signs of distress were observed or reported. Pt was provided with education on what to expect, adverse effects, and when to seek care ? both verbal and written ? on both the Flu and COVID-19 vaccine.
He had chest pains 4 days following the injections. On the 5th day the pain became very severe and constant. He was taken to clinic. She gave him a breating treatment with albuterol, with no positive effect on his pain. She followed that up with 400 mg of ibuprofen. He didn't have any relief from the pain following the ibuprofen. Dr. then ordered some blood work, x-rays, and an EKG. We had to follow up with Dr. on Monday, Feb. 1st. Dr. said everything looked good, but we were waiting for the pediatric radiologist to read the  EKG. He eyesight has also been effected. It is blury and double vision.
Child at daycare. Daycare called mtr. to tell her child had fever of 102.8; and unable to walk. Mtr. states "leg went out". Mtr took child to Emergency Room and ER diag. Cellulitis-gave antibiotics inst. cold packs for swelling. 12/13/12 mtr states child better fever reduced, is able to walk, however not completely resolved.
Extremely strong shivering for several hours Loss of coordination after standing up Fainting after standing up
Patient was given a 2nd dose of the bivalent vaccine 3 weeks after initial bivalent booster